Introducing a Single IV Abatacept Treatment in RA Patients Currently Receiving Weekly SC Abatacept to Simulate a Holiday
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Methotrexate-Inadequate Response Autoinjector Device Sub Study
- Status
- COMPLETED
- Phase
- PHASE3
Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs)
- Status
- COMPLETED
- Phase
- PHASE3
Phase 3 Study of Nivolumab or Nivolumab Plus Ipilimumab Versus Ipilimumab Alone in Previously Untreated Advanced Melanoma (CheckMate 067)
- Status
- COMPLETED
- Phase
- PHASE3
Pramlintide (Symlin) for the Treatment of Hypoglycemia Following Gastric Bypass Surgery
- Status
- COMPLETED
- Phase
- PHASE4
Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Phase I Study of Intralesional Bacillus Calmette-Guerin (BCG) Followed by Ipilimumab in Advanced Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
Bioequivalence Study of Individual Atazanavir and Cobicistat Compared With Atazanavir in Fixed-dose Combination With Cobicistat
- Status
- COMPLETED
- Phase
- PHASE1
Early Conversion From CNI to Belatacept in Renal Transplant Recipients With Delayed and Slow Graft Function
- Status
- UNKNOWN
- Phase
- PHASE2
Effect of SAR302503 on ECG Activity in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in Japan
- Status
- COMPLETED
- Phase
- PHASE3
Pharmacokinetic and Safety Study of Daclatasvir in Patients With Renal Impairment
- Status
- COMPLETED
- Phase
- PHASE1
A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based
- Status
- COMPLETED
- Phase
- PHASE3
Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir
- Status
- COMPLETED
- Phase
- PHASE1
Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Dasatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy and Safety Evaluation of a Treatment Consisting of Peg Interferon Alfa + Ribavirin + Daclatasvir in HCV Genotype 1 and 4 Treatment naïve Patients
- Status
- WITHDRAWN
- Phase
- PHASE3
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin
- Status
- COMPLETED
- Phase
- PHASE2
Brigham and Women's Rheumatoid Arthritis Sequential Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Pharmacokinetics, Safety and Tolerability of Single-dose Belatacept in Adolescent Kidney Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE2